1. Choi, C.H. (2005) ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int., 5, 30.
2. Chu, J.J., Chiang, C.D., Rao, C.S., Chang, W.M. & Lai, Y.K. (2000) Establishment and characterization of a paclitaxel-resistant human non-small cell lung cancer cell line. Anticancer Res., 20, 2449-2456.
3. Cuny, M., Kramar, A., Courjal, F., Johannsdottir, V., Iacopetta, B., Fontaine, H., Grenier, J., Culine, S. & Theillet, C. (2000) Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations. Cancer Res., 60, 1077-1083.
4. Duan, Z., Lamendola, D.E., Duan, Y., Yusuf, R.Z. & Seiden, M.V. (2005) Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines. Cancer Chemother. Pharmacol., 55, 277-285.
5. Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. & Bray, F. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 136, E359-E386.